New MMR vaccine tested in african children to match established protection
⭐️ VACCINE ⭐️
Completed
This study tested a new MMR vaccine made by Shanghai Institute of Biological Products to see if it works as well as an already approved vaccine from GSK. It involved 1,200 healthy African children aged 9-11 months. Researchers compared the children's immune responses and monitore…
Phase: PHASE3 • Sponsor: Shanghai Institute Of Biological Products • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 17, 2026 13:09 UTC